Acceleron Pharma Inc.

NASDAQ: XLRN · Real-Time Price · USD
178.75
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Acceleron Pharma Revenue Breakdown

Period Ending Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Cost Sharing Revenue 12.67M 60M 13.99M
Cost Sharing Revenue Growth -78.88% +328.85% n/a
License and Service Revenue 25M n/a n/a
License and Service Revenue Growth n/a n/a n/a
Royalty Revenue 54.85M n/a n/a
Royalty Revenue Growth n/a n/a n/a

Operating Expense Breakdown

Period Ending Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 45.11M 35.47M 31.06M 26.21M 21.04M 20.41M 18.25M 16.09M 15.5M 14.04M 10.81M 10.75M 8.65M 7.66M 7.44M 7M 7.53M 11.37M 7.84M 6.27M 6.41M 6.71M 5.91M 5.78M 5.43M 4.66M 4.7M
Selling, General, and Administrative Revenue Growth +27.18% +14.20% +18.53% +24.55% +3.08% +11.84% +13.44% +3.81% +10.43% +29.80% +0.62% +24.20% +12.99% +2.92% +6.25% -7.04% -33.75% +45.10% +25.02% -2.23% -4.48% +13.55% +2.34% +6.31% +16.56% -0.83% n/a
Research and Development Revenue 59.72M 56.13M 57.3M 57.25M 40.75M 38.25M 37.66M 48.83M 37.63M 34.77M 32.77M 29.88M 24.67M 25.93M 23.43M 25.34M 21.06M 21.6M 21.73M 19.09M 17.1M 16.14M 16.25M 16.14M 13.34M 14.15M 14.78M
Research and Development Revenue Growth +6.39% -2.04% +0.08% +40.51% +6.53% +1.56% -22.87% +29.76% +8.24% +6.08% +9.69% +21.11% -4.88% +10.68% -7.53% +20.32% -2.50% -0.59% +13.83% +11.61% +5.97% -0.66% +0.64% +21.06% -5.76% -4.26% n/a